Theratechnologies Inc (TSE:TH) is set to issue its quarterly earnings data before the market opens on Thursday, September 29th. Analysts expect the company to announce earnings of $0.01 per share for the quarter.
Shares of Theratechnologies Inc (TSE:TH) opened at 2.93 on Tuesday. The stock’s 50 day moving average price is $2.60 and its 200 day moving average price is $2.41. The stock has a market cap of $193.18 million and a price-to-earnings ratio of 266.36. Theratechnologies Inc has a 52 week low of $1.26 and a 52 week high of $3.74.
Several brokerages have recently commented on TH. Mackie reduced their price target on shares of Theratechnologies from C$5.30 to C$4.40 in a research report on Wednesday, July 6th. Canaccord Genuity reduced their price target on shares of Theratechnologies from C$4.25 to C$3.75 in a research report on Thursday, July 7th. Finally, National Bank Financial cut shares of Theratechnologies from an “outperform market weight” rating to a “sector perform market weight” rating in a research report on Wednesday, July 6th.
Theratechnologies Company Profile
Theratechnologies Inc is a Canada-based specialty pharmaceutical company. The Company addresses medical needs in metabolic disorders to promote healthy ageing among human immunodeficiency virus (HIV) patients. The Company’s product, EGRIFTA (tesamorelin for injection), is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.
Receive News & Ratings for Theratechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.